New research from UC Davis Comprehensive Cancer Center has uncovered an evolutionary change that may explain why certain ...

Our study explores the potential value of TCTP as a prognostic marker in metastatic colon cancer. Methods: A retrospective analysis of 54 patients with primary metastatic colon cancer was performed.

Colon cancer remains a leading cause of mortality worldwide despite the well-characterized molecular events in the adenoma-to-carcinoma sequence. There has been a strong emphasis on early ...

From 2011 to 2019, incidence of colon cancer fell by about 1% annually, mainly among older adults. In people younger than 55, rates have been growing by 1% to 2% a year since the mid-1990s.

Researchers have created model tumors using the tissues of patients with advanced bowel cancer and used them to predict how the disease will respond to specific drug therapies – before treatment ...

This presentation will discuss important pre-analytical, analytical, and post-analytical factors that clinical labs should consider when offering tumor marker testing. Limitations of tumor markers and ...

Disruption of DNA repair mechanisms is a major cause of increased cancer risk. About 20% of bowel cancers, known as mismatch repair deficient (MMRd) cancers, are caused by mutations in DNA repair ...

Researchers engineered a probiotic bacteria to release a marker that can be detected in the urine after it comes into contact with bowel cancer, even when it's in the early stages. The novel test ...

From 2011 to 2019, incidence of colon cancer fell by about 1% annually, mainly among older adults. In people younger than 55, rates have been growing by 1% to 2% a year since the mid-1990s.

New bowel tumor drug helped cure cancer in 100% of cases. By Chris Smith. Published Jun 4th, 2024 1:56PM EDT. Image: Alernon77/Adobe.